XML 62 R23.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stock-Based Compensation Plans
9 Months Ended
Sep. 30, 2015
Equity [Abstract]  
Stock-Based Compensation Plans

NOTE 14 – STOCK-BASED COMPENSATION PLANS

The Company grants stock options and stock equivalent units (“SEUs”) from time to time as a long-term performance incentive. In certain cases the grants are subject to performance conditions such as the Company’s stock price. Where performance conditions apply the Monte Carlo simulation model is used to determine the fair values. Otherwise the Black-Scholes model is used to determine the fair values.

Stock option plans

The following table summarizes the transactions of the Company’s stock option plans for the nine months ended September 30, 2015:

 

     Number of
Options
     Weighted
Average
Exercise
Price
     Weighted
Average
Grant-Date
Fair Value
 

Outstanding at December 31, 2014

     728,640       $ 19.55      

Granted - at discount

     69,217       $ 0.00       $ 37.55   

 - at market value

     23,550       $ 43.95       $ 9.89   

Exercised

     (132,614    $ 7.48      

Forfeited

     (4,431    $ 14.63      

Expired

     (20,552      0.00      
  

 

 

       

Outstanding at September 30, 2015

     663,810       $ 20.30      
  

 

 

       

At September 30, 2015, there were 108,061 stock options that were exercisable, of which 36,130 had performance conditions attached.

 

The stock option compensation cost for the first nine months of 2015 was $2.7 million (2014 – $1.7 million). The total intrinsic value of options exercised in the first nine months of 2015 was $2.1 million (2014 – $0.9 million).

The total compensation cost related to non-vested stock options not yet recognized at September 30, 2015 was $4.7 million and this cost is expected to be recognized over the weighted-average period of 2.03 years.

Stock equivalent units

The following table summarizes the transactions of the Company’s SEUs for the nine months ended September 30, 2015:

 

     Number
of SEUs
     Weighted
Average
Exercise
Price
     Weighted
Average
Grant-Date
Fair Value
 

Outstanding at December 31, 2014

     286,563       $ 3.41      

Granted - at discount

     69,280       $ 0.00       $ 36.65   

- at market value

     7,552       $ 43.95       $ 9.89   

Exercised

     (93,840    $ 2.01      

Forfeited

     (1,495    $ 29.56      
  

 

 

       

Outstanding at September 30, 2015

     268,060       $ 4.01      
  

 

 

       

At September 30, 2015 there were 62,745 SEUs that are exercisable, of which 52,693 had performance conditions attached.

The charges for SEUs are spread over the life of the award subject to a revaluation to fair value each quarter. The revaluation may result in a charge or a credit to the income statement in the quarter dependent upon our share price and other performance criteria.

The SEU compensation cost for the first nine months of 2015 was $2.4 million (2014 - $0.3 million). The total intrinsic value of SEUs exercised in the first nine months of 2015 was $2.2 million (2014 – $3.5 million).

The weighted-average remaining vesting period of non-vested SEUs is 1.54 years.

Additional exceptional long-term incentive plan

A maximum of $3.0 million of our cash-settled long-term incentives is accounted for as share-based compensation and the fair value is calculated on a quarterly basis using a Monte Carlo model. The fair values at each of the balance sheet dates are summarized as follows:

 

(in millions)

   2015      2014  

Balance at January 1

   $ 0.1       $ 0.0   

Compensation charge for the period

     0.4         0.1   
  

 

 

    

 

 

 

Balance at September 30

   $ 0.5       $ 0.1   
  

 

 

    

 

 

 

 

The following assumptions were used in the Monte Carlo model at September 30:

 

     2015     2014  

Dividend yield

     1.25     1.45

Volatility of Innospec’s share price

     24.47     28.96

Risk free interest rate

     0.92     1.07